GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity - Wikidata - wikimedia - TriplyDB

GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity

GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity

http://www.wikidata.org/entity/Q33893993

about

Regulation of glucose homeostasis by GLP-1 Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-catenin Erythropoietin: new directions for the nervous system Targeting disease through novel pathways of apoptosis and autophagy Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?Nanoparticle ligand presentation for targeting solid tumors Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy New Insights for Oxidative Stress and Diabetes Mellitus Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets The role of the Wnt signaling pathway in incretin hormone production and function.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade Novel directions for diabetes mellitus drug discovery GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs Incretins: their physiology and application in the treatment of diabetes mellitus.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Novel Pentapeptide GLP-1 (32-36) Amide Inhibits β-Cell Apoptosis In Vitro and Improves Glucose Disposal in Streptozotocin-Induced Diabetic Mice.Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.Fibroblast growth factor 21 and its novel association with oxidative stress.GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice.Allantoin ameliorates chemically-induced pancreatic β-cell damage through activation of the imidazoline I3 receptors mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.The bright side of reactive oxygen species: lifespan extension without cellular demise.GLP-1(28-36)amide, a Long Ignored Peptide Revisited.GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.Energy depletion and not ROS formation is a crucial step of glucolipotoxicity (GLTx) in pancreatic beta cells.Fatty Acids, Antioxidants and Physical Activity in Brain Aging.Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1

P2860

Q24563430-0990B7C8-892F-4E4A-AF21-2DA3D34D101D Q26749047-0838828B-1148-4216-81C5-51625AB8C836 Q26800615-F7D91BB7-26BD-4505-8EDF-3CDF0704D2DB Q26823824-8CA421E1-15F9-4E0E-9A5D-33B206B2ABF8 Q26828425-8B7D21FE-C3FE-41EC-B4DB-EA3A6F636604 Q26864639-1F2CF239-4D80-4E11-866D-16CBC4BDB541 Q26866054-E5F4D6E9-F09A-45F3-B65B-9689EE596733 Q27009522-C9C09DB9-D170-4C3E-B679-4E3D06B7A168 Q28066377-4F607B31-5749-43B0-8775-02252F19BBE3 Q28080679-6DC49173-A076-4298-842F-7EF7B7DDD3FB Q28085715-EFD68A7A-A1C9-42F9-8AF2-8829DC355AC4 Q33734024-CD2F6B6D-9EAE-4B59-93A9-EA6B455E51AE Q33783000-5573CB04-444E-49DB-A482-F9509C799D05 Q35769544-A9FF9AB1-CD06-455A-A67F-1E55C2328532 Q35827634-105C13EE-1D19-40C5-BFB2-CDA99942E59B Q36193707-DD44A871-27EE-45D3-80F8-C4C7E072F732 Q36432388-CDEEA6F4-7474-4902-B393-B9F3250D6CE2 Q36487424-555259F7-A632-433E-ACDC-95CCC81AA35F Q37501537-4C10AA4E-B9F9-4C4E-9890-32D3782CC0C8 Q38225693-B0B347B3-7A02-4EA5-9EEB-9A8CD219A525 Q38367977-EAFB69DA-5781-49E9-A6CD-B0D34D3D8EA0 Q38852616-48868CE6-B2DC-4A18-90B9-730E20962C32 Q38923365-156348D3-C89D-4B89-AC4C-497012E22FA5 Q39063540-64C13776-36CD-4D67-B017-3DF1EED15874 Q39063954-823584E3-6FBC-4238-8011-9D723CAE0285 Q39168828-27987A2F-977E-47C3-8921-88A402C96694 Q41203575-93BF169A-D25E-4DAE-A72B-4010C2F53AAF Q41980480-EBEDA07F-710A-479F-A7C6-A0C6FD958576 Q42031136-5C55977C-B9E7-4012-B561-C8783711EB8A Q42782106-616FBFBF-3384-4C9E-BBD1-2A75597A022F Q43105364-3F0575A3-D645-4339-93BF-36DE4C63D15E Q43636905-959F1149-50FD-469A-826F-E77DFCDEC98C Q46245542-932482B5-05B5-495E-A4DF-F1EEEF08E8E1 Q47156198-4B23A9C5-D4BF-4096-A280-F5538DC70C0E Q58572799-57A05C3F-6C4C-4005-B7D4-CF064157BEA1

P2860

GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity

http://www.wikidata.org/entity/Q33893993

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@ast

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@en

type

label

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@ast

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@en

prefLabel

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@ast

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@en

P1433

Q33893993-6F5564AC-2F2A-4083-88B7-7516C35F9208

P1476

Q33893993-4521438A-F833-44DF-A3C8-69AE48216809

P2093

Q33893993-07BFC940-8843-467E-B0ED-BBE3648E93BC

Q33893993-2343CA94-C7D9-441C-98DA-7149676AD2A7

Q33893993-5F960678-AFAC-4E66-8267-1464EC7BA519

Q33893993-DFDB8A3B-AF22-46C5-9988-F36EBFFBCF79

P2860

Q33893993-001D20AD-A36C-4D2A-99E3-8952AA547952

Q33893993-01DCD3C3-A39E-4B0B-8CAC-C28255C94DA9

Q33893993-0C3A68EE-585D-48A8-B276-4A72E8A5C4FA

Q33893993-137A0A39-7505-49B8-BECA-5B85B29B5145

Q33893993-197C0487-0CFF-4B27-852C-EF78CE25C257

Q33893993-1A19DA7E-23D8-47BD-B5BF-6DED5AFF7658

Q33893993-20CCEEF0-E0F6-4322-9C11-293A95435DDB

Q33893993-36B72F78-5EB7-4C9F-AE66-3C78C8394B3C

Q33893993-374BF868-E92D-44E2-8A8B-040C70408A86

Q33893993-38E6008B-5EF4-4CBA-9ADB-89E620934A9D

P304

Q33893993-AF355E34-E01D-4479-85EF-B41B0CC21EA1

P31

Q33893993-B405EEA7-564F-473B-B49F-68307FFE5C6D

P356

Q33893993-3F3FF41E-D460-47FC-9770-3B4FB3140731

P407

Q33893993-12E1B12B-E482-456F-9199-F07AC426A523

P433

Q33893993-31A1507D-37F9-4589-9DE4-F8D480479F3B

P478

Q33893993-F345B08A-A983-47BA-AEF6-D64328DDCC04

P577

Q33893993-A2F82DBD-618C-4E64-BF0E-FC396BD4D35D

P698

Q33893993-7A55EAA3-0432-4905-A2BD-D4F549FA1612

P932

Q33893993-C6111DEA-191F-436B-A626-4326A90E3101

P356

P1433

Journal of Endocrinology

P1476

GLP1-derived nonapeptide GLP1( ...... β-cells from glucolipotoxicity

@en

P2093

Joel F Habener

http://www.w3.org/2001/XMLSchema#string

Luke J Brindamour

http://www.w3.org/2001/XMLSchema#string

Violeta Stanojevic

http://www.w3.org/2001/XMLSchema#string

Zhengu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation

Oxidative stress, nitric oxide, and diabetes.

Cell-permeable, mitochondrial-targeted, peptide antioxidants.

Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Transport systems for opioid peptides in mammalian tissues.

Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus

Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

The replication of beta cells in normal physiology, in disease and for therapy.

Hexarelin Signaling to PPARgamma in Metabolic Diseases.

P304

143-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/JOE-11-0328

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

213

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22414687

http://www.w3.org/2001/XMLSchema#string

P932

4096040

http://www.w3.org/2001/XMLSchema#string